Trial Profile
A double-blind, placebo-controlled investigation into the safety and efficacy of escitalopram for depression in multiple sclerosis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression; Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 28 Oct 2006 New trial record.